Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rapoport

Showing results (121-130 of 179) with videos related to

Pageof 18
Sort By:
Blood Advances|July 11, 2019
Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myelomaEdward A Stadtmauer, Thomas H Faitg, Daniel E Lowther, et al.
Plos One|November 5, 2015
Concurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell LymphomaHaley M Simpson, Rashid Z Khan, Chang Song, et al.
Blood Advances|December 23, 2021
Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapySaurabh Dahiya, Tim Luetkens, Forat Lutfi, et al.
Bone Marrow Transplantation|August 28, 1998
Autotransplantation for relapsed or refractory Hodgkin's disease: long-term follow-up and analysis of prognostic factorsJ E Lancet, A P Rapoport, R Brasacchio, et al.
The British Journal of Ophthalmology|February 11, 2022
Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and reviewAisha A Mumtaz, Andrew Fischer, Forat Lutfi, et al.
Blood Reviews|June 9, 2024
Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotideClifton C Mo, Edward Richardson, Eleonora Calabretta, et al.
Cytotherapy|February 10, 2024
A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell productsDjordje Atanackovic, Thierry Iraguha, Destiny Omili, et al.
Blood Advances|February 5, 2024
Outcomes of subsequent antilymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7Armin Ghobadi, Javier Munoz, Jason R Westin, et al.
Acta Haematologica|August 27, 2024
Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell TransplantationGabriela Sanchez-Petitto, Olga Goloubeva, James Childress, et al.
Bone Marrow Transplantation|May 1, 1997
Autotransplantation for relapsed or refractory non-Hodgkin's lymphoma (NHL): long-term follow-up and analysis of prognostic factorsA P Rapoport, R Lifton, L S Constine, et al.
Pageof 18

Showing results (121-130 of 179) with videos related to

Sort By:
Pageof 18
Blood Advances|July 11, 2019
Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myelomaEdward A Stadtmauer, Thomas H Faitg, Daniel E Lowther, et al.
Plos One|November 5, 2015
Concurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell LymphomaHaley M Simpson, Rashid Z Khan, Chang Song, et al.
Blood Advances|December 23, 2021
Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapySaurabh Dahiya, Tim Luetkens, Forat Lutfi, et al.
Bone Marrow Transplantation|August 28, 1998
Autotransplantation for relapsed or refractory Hodgkin's disease: long-term follow-up and analysis of prognostic factorsJ E Lancet, A P Rapoport, R Brasacchio, et al.
The British Journal of Ophthalmology|February 11, 2022
Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and reviewAisha A Mumtaz, Andrew Fischer, Forat Lutfi, et al.
Blood Reviews|June 9, 2024
Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotideClifton C Mo, Edward Richardson, Eleonora Calabretta, et al.
Cytotherapy|February 10, 2024
A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell productsDjordje Atanackovic, Thierry Iraguha, Destiny Omili, et al.
Blood Advances|February 5, 2024
Outcomes of subsequent antilymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7Armin Ghobadi, Javier Munoz, Jason R Westin, et al.
Acta Haematologica|August 27, 2024
Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell TransplantationGabriela Sanchez-Petitto, Olga Goloubeva, James Childress, et al.
Bone Marrow Transplantation|May 1, 1997
Autotransplantation for relapsed or refractory non-Hodgkin's lymphoma (NHL): long-term follow-up and analysis of prognostic factorsA P Rapoport, R Lifton, L S Constine, et al.
Pageof 18